Value of gastric cancer clinical decision support system in a single-center clinical application

Table 1 Clinical features of patients, n (%)

Clinical features
Gender
Male	94 (60.3)
Female	62 (39.7)
Age (years)
< 40	6 (3.8)
40-50	24 (15.4)
50-60	38 (24.4)
60-70	45 (28.8)
70-80	31 (19.9)
≥ 80	12 (7.7)
Category of disease severity
New cases	110 (70.5)
Previous cases	28 (17.9)
Recurrent cases	18 (11.5)
Treatment
Surgery	82 (52.6)
Neoadjuvant chemotherapy	7 (4.5)
Adjuvant therapy	11 (7.1)
Palliative systemic therapy	45 (28.8)
Supportive treatment	11 (7.1)
Tumor, node, metastasis classification
Stage 0	1 (0.6)
Stage I	24 (15.4)
Stage II	21 (13.5)
Stage III	49 (31.4)
Stage IV	61 (39.1)
Total	156

Table 2 Comparison of concordance of different groups

Group	Consistent	Inconsistent	Concordance rate (%)
Category of disease severity
New cases	105	5	95.5
Previous case	21	7	75.0
Recurrent cases	15	3	83.3
Tumor, node, metastasis classification
Stage 0	1	0	100
Stage I	24	0	100
Stage II	21	0	100
Stage III	44	5	89.8
Stage IV	51	10	83.6
Treatment
Surgery	80	2	97.6
Neoadjuvant chemotherapy	7	0	100
Adjuvant therapy	8	3	72.7
Palliative systemic therapy	35	10	77.8
Supportive treatment	11	0	100
Total	141	15	90.4